Everlight Solar Wins Comparably's 2023 Best Company Culture Award
This recognition exemplifies the company's unwavering commitment to creating an environment where their team members feel valued, fulfilled, and can have fun at work. In an anonymous survey, one Everlight Solar staff member shared, "The support from our leaders (and everyone, really) is unmatched. We push each other upward and inspire one another every day. It's the most inspirational job I've ever had!" From leadership and mentorship to work-life balance and the camaraderie among coworkers, every aspect of Everlight Solar's company culture has played a pivotal role in achieving this remarkable recognition.
Receiving the Best Company Culture award marks the twelfth recognition the company has received from Comparably, amongst Best CEO, Best Career Growth, and Best Company Outlook, all received in 2023 alone. The company also received this recognition in 2022, making this the second time they have received this award.
Another staff member from the company shared, "Everybody at Everlight has a smile on their face and meets everyday challenges with optimism and confidence. Can't help but be happy every day." Everlight Solar stands behind its commitment to fostering the growth and satisfaction of its staff as it collaboratively strives for a more sustainable future.
They extend their heartfelt thanks to their exceptional team for making Everlight Solar a remarkable workplace. As a collective, Everlight Solar strives to empower its team personally and professionally.
About Everlight Solar
Everlight Solar is the fastest-growing solar company in the Midwest, with operations in
View original content to download multimedia:https://www.prnewswire.com/news-releases/everlight-solar-wins-comparablys-2023-best-company-culture-award-302019355.html
SOURCE Everlight Solar
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PwC US and PwC India Form Joint Venture to Help Clients Grow and Compete at Greater Speed and Scale
- Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026
- Doginal Dogs Reports Record Turnout at DDNYC 2026, Its Largest Event to Date
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share